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Abstract
Recently, two genome scan meta-analysis studies have found strong evidence for the association of loci on chromosome 8p
with schizophrenia. The early growth response 3 (EGR3) gene located in chromosome 8p21.3 was also found to be involved
in the etiology of schizophrenia. However, subsequent studies failed to replicate this finding. To investigate the genetic role
of EGR3 in Chinese patients, we genotyped four SNPs (average interval ,2.3 kb) in the chromosome region of EGR3 in 470
Chinese schizophrenia patients and 480 healthy control subjects. The SNP rs35201266 (located in intron 1 of EGR3) showed
significant differences between cases and controls in both genotype frequency distribution (P=0.016) and allele frequency
distribution (P=0.009). Analysis of the haplotype rs35201266-rs3750192 provided significant evidence for association with
schizophrenia (P=0.0012); a significant difference was found for the common haplotype AG (P=0.0005). Furthermore,
significant associations were also found in several other two-, and three-SNP tests of haplotype analyses. The meta-analysis
revealed a statistically significant association between rs35201266 and schizophrenia (P=0.0001). In summary, our study
supports the association of EGR3 with schizophrenia in our Han Chinese sample, and further functional exploration of the
EGR3 gene will contribute to the molecular basis for the complex network underlying schizophrenia pathogenesis.
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Introduction
Schizophrenia (OMIM 181500) is a severe mental disorder with
a lifetime risk of about 1%, characterized by hallucinations,
delusions and cognitive deficits. Family, twin and adoption studies
have consistently demonstrated an important genetic component
to schizophrenia (,80%), in addition to developmental and
environmental influences [1,2].
Identification of susceptibility genes associated with schizophre-
nia has been difficult. This is presumably due to the etiological
complexity and abnormalities in development of this psychiatric
disease.Inspite ofthesedifficulties,chromosome region 8phasbeen
shown to be the most well-established association with schizophre-
nia.Recently,twogenome-scanmeta-analysisstudiesforpsychiatric
diseases have found strong evidence for the association of 8p with
schizophrenia [3,4]. In addition, a genome-scan study with a large
sample of pedigrees has added further evidence for the hypothesis
that at least one schizophrenia susceptibility gene may be located on
chromosome 8p [5]. More recently, a number of liability genes
located in chromosome 8p were found to be involved in the etiology
of schizophrenia. EGR3 is one of these compelling susceptibility
genesthat havebeen associated with schizophrenia invariousethnic
populations [6,7,8,9,10,11].
Early growth response (EGR)g e n e s( EGR1, EGR2, EGR3,a n d
EGR4) are a family of immediate earlygene transcription factors that
are important for neuronal responses [12]. All the family members
share a highly conserved DNA-binding domain composed of three
zinc-finger motifs. They play an important role in the mediation of
gene transcription in neuronal development and are involved in the
regulation of synaptic plasticity, learning and memory process
[13,14]. EGR1 and EGR3 are the most abundant EGR proteins in
the brain, and their expression is up-regulated by synaptic activity in
the brain [15]. EGR3 has an essential role in learning and memory
processing of both short- and long-term hippocampus-dependent
memory; it also mediates adaptation to stress and novelty [15,16].
Therefore, EGR3 is a compelling candidate gene for schizophrenia
from functional and positional perspective.
Expression of EGR3 has been reported to be significantly lower
in postmortem hippocampus’ of schizophrenic patients compared
to the control subjects [17]. Expression of EGR3 was also reported
to be down-regulated in the dorsolateral prefrontal cortex of
patients with schizophrenia. Moreover, pedigree and case-control
analyses in a study utilizing a Japanese sample found that EGR3
was significantly associated with schizophrenia; this result was also
replicated in a Korean population study [8,11]. However,
subsequent studies utilizing a Japanese sample and a Chinese
sample failed to replicate this finding [18,19].
As a result of the ‘‘winner’s curse’’ phenomena, a seemingly
high proportion of false positive reports caused by the overesti-
mation of genetic effects were published. A stringent criterion for
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study should be viewed as tentative until it has been independently
replicated in at least one other study [20]. Hence, we performed a
study to further explore the relationship between EGR3 and
schizophrenia in a case-control sample of Chinese.
Results
We genotyped four SNPs (average interval ,2.3 kb) in the
chromosome region of EGR3 in 470 Chinese schizophrenia
patients and 480 control subjects (Figure 1). Hardy-Weinberg
equilibrium (HWE) was tested separately in case and control
samples. The genotype distribution of SNPs rs35201266,
rs3750192, and rs1877670 were found to be in HWE (P.0.05)
both in controls and cases. The genotype distribution of rs1008949
was not in HWE in patients (P,0.05). All SNPs were highly
polymorphic in both groups.
Single-marker analysis
The genotype and allele frequency distribution of all the SNPs
in schizophrenia patients and controls are shown in Table 1. SNP
rs35201266 showed significant differences between cases and
controls both in the genotype frequency distribution (X
2=8.25,
P=0.016) and the allele frequency distribution (the A-allele:
X
2=6.829, P=0.009, odds ratio (OR)=1.37, 95% confidence
intervals (CI)=1.07–1.75). Moreover, in the genetic model
analysis (Table 2), a significantly positive result was observed for
the A-allele of rs35201266 in the additive model (X
2=7.09,
P=0.0078, OR=1.46), and weakly positive results were found in
the dominant model (X
2=7.09, P=0.0258, OR=1.36,
95%CI=1.04–1.79) and the recessive model (X
2=5.21,
P=0.0224, OR=2.69, 95%CI=1.11–6.50). After Bonferroni
correction, the difference observed for rs35201266 (P=0.036) in
the allele frequency distribution and the additive model (P=0.031)
remained significant.
Haplotype analysis
Figure 2 presents the results of Linkage disequilibrium (LD) tests
between pairs of SNP markers for the respective control groups.
Owing to the medium LD (D9.0.8) between rs1008949 and
rs35201266, we selected the rs35201266 as the relevant tagging
SNP for haplotype analyses. Analysis of haplotype rs35201266-
rs3750192 showed significant association with schizophrenia
(global P=0.0012). A significant difference was found for the
common haplotype AG (P=0.0005, OR=1.77, 95% CI=1.27–
2.47) which was more prevalent in cases compared to controls
(11.4% vs 6.8%). After correction for multiple testing (4 haplotypes
and 4 allelic comparisons), the difference observed for the AG
haplotype (P=0.004) remained significant. In addition, several
other two-, and three-SNP tests of haplotype association were also
significant (Table 3). Haplotypes containing the A allele of
rs35201266, were higher in frequency in cases compared to
controls.
Age at onset (AAO) analysis
Since the marker rs35201266 showed significant association
with schizophrenia, and schizophrenia onset is quite concentrated
for people between the ages of 15 and 45 [21], we stratified the
patients into 4 subgroups by AAO to examine if there were any
clinical differences between the patients carrying allelic variants of
rs35201266 (Table 4). However, no significant differences were
found between the risk allele (A) carriers and the G homozygotes
of rs35201266 (Global P=0.2764). When the allele frequencies
were compared in different subgroups between the A carriers and
the G homozygous carriers, no significant differences were
observed (P.0.1).
Gender analysis
Samples were stratified by gender according to the study of
Zhang et al. [22] and marker rs35201266 was analyzed in patients.
For the A carriers and the G homozygotes of rs35201266, there
was no significant difference (P=0.0794, OR=0.71, 95%
CI=0.48–1.06) between males and females (Table 4).
Comparing our results with previous association studies
A comparison of our results with the previous genetic studies
have been performed, and the A-allele of rs35201266 showed the
positive results in Chinese (P=0.009), Korean (P=0.0008), and a
part of Japanese population (P=0.0009) (Table 5). We also found
that the MAF of rs35201266 was lower in the Chinese population
compared to other populations (Table 5).
When we compared our results with previous GWASs on
schizophrenia (Table 6), the positive association between chromo-
some 8p and disease was identified at least in four different ethnic
populations from three GWASs [23,24,25].
Meta-analysis
For the meta-analysis, we combined and analyzed data from six
populations (including this study). We utilized the schizophrenia
research forum (http://www.szgene.org) and identified five
independent case-control studies that tested for associations
between various SNPs of EGR3 and schizophrenia
[8,11,18,19,26]. The study of Mansour et al. [26] did not provide
enough information to calculate an effect of size, and therefore,
was excluded from further analysis. We combined SNP data from
the remaining studies and separately examined three SNPs
(rs1008949, rs35201266 and rs3750192) in the EGR3 gene locus.
Summary statistics of the meta-analysis for these three SNPs are
shown in Figure 3.
We tested for heterogeneity for each SNP of the combined
sample, and the results were not significant [rs1008949 (X
2=5.26,
df=3, P=0.15), rs35201266 (X
2=4.40, df=2, P=0.11) and
rs3750192 (X
2=4.24, df=3, P=0.24)], enabling us to test for
association of each of the SNPs by using a fixed-effect meta-
analysis. A significant difference was found between patients and
controls for the A-allele of rs35201266 (Subtotal OR=1.27,
95%CI=1.12–1.43, Z=3.87, P=0.0001), but not for rs1008949
Figure 1. Organization and position of selected SNPs of EGR3.
doi:10.1371/journal.pone.0030237.g001
The EGR3 Gene and Schizophrenia
PLoS ONE | www.plosone.org 2 January 2012 | Volume 7 | Issue 1 | e30237(Subtotal OR=1.03, 95%CI=0.95–1.12, Z=0.75, P=0.45) and
rs3750192 (Subtotal OR=1.0, 95%CI=0.89–1.12, Z=0.02,
P=0.98).
Since only one family-based association study yielded a
significant association (P=0.0009) [8], we didn’t perform a
family-based meta-analysis.
Discussion
In the current study, we found that SNP rs35201266 of EGR3
and several haplotypes comprised of rs35201266 were significantly
associated with schizophrenia patients of Han Chinese origin. Our
SNP result is consistent with the findings of previous studies that
were performed utilizing a Japanese sample of family-trios and a
Korean case-control sample [8,11]. A comparison of our results
with the previous studies indicated that the A-allele of rs35201266
may be a risk allele for schizophrenia in Chinese, Korean, and a
part of Japanese population. We also found that the MAF of
rs35201266 was lower in the population we studied compared to
other populations. This difference may be due to differences in
ethnic backgrounds [27].
In the genetic model analysis, SNP rs35201266 showed strongly
significant differences between cases and controls both in the
additive model analysis (P=0.0078) and the allelic comparisons
(P=0.009). Together with the weakly significant P value in the
dominant model (P=0.0258) and the recessive model (P=0.0224),
Table 1. Genotype and allele frequencies of the SNPs analyzed in cases and controls.
Marker Genotype Distribution (%) Allele Distribution (%)
Genotype Case
a Control
a X
2 P value
b Allele Case
a Control
a X
2 P value
b OR (95% CI)
rs1008949 CC 30.8(145) 32.3(155) 3.29 0.193 C 58.2(547) 57.1(548) 0.239 0.625 1.05 (0.87–1.26)
CT 54.7(257) 49.6(238) T 41.8(393) 42.9(412)
TT 14.5(68) 18.1(87)
rs35201266 AA 3.8(18) 1.5(7) 8.25 0.016 A 20.1(189) 15.5(149) 6.829 0.009 1.37 (1.07–1.75)
AG 32.6(153) 28.1(135) G 79.9(751) 84.5(811)
GG 63.6(299) 74.4(338)
rs3750192 GG 71.9(338) 66.3(318) 3.78 0.151 G 84.1(791) 81.3(780) 2.788 0.095 1.23 (0.96–1.57)
GT 24.5(115) 30.0(144) T 15.9(149) 18.7(180)
TT 3.6(17) 3.7(18)
rs1877670 TT 30.0(141) 27.9(134) 0.55 0.758 T 55.3(520) 54.3(521) 0.211 0.646 1.04 (0.87–1.26)
TC 50.6(238) 52.7(253) C 44.7(420) 45.7(439)
CC 19.4(91) 19.4(93)
aNumber of alleles for each SNP is given in parentheses.
bSignificant P value (,0.05) are in boldface.
doi:10.1371/journal.pone.0030237.t001
Table 2. Analysis of the genetic models.
Marker Genotype
a
Dominant Model
(Risk allele 1)
Recessive Model
(Risk allele 1) Additive Model (Risk allele 1)
11 12 22 X
2 P value
b OR (95% CI) X
2 P value
b OR (95% CI) X
2 P value
b OR
c
rs1008949 0.23 0.6329 1.07 (0.81–1.41) 2.33 0.1272 0.76 (0.54–1.08) 0.26 0.6129 0.94
Cases 68 257 145
Controls 87 238 155
rs35201266 4.97 0.0258 1.36 (1.04–1.79) 5.21 0.0224 2.69 (1.11–6.50) 7.09 0.0078 1.46
Cases 18 153 299
Controls 7 135 338
rs3750192 3.57 0.0590 0.77 (0.58–1.01) 0.01 0.9134 0.96 (0.49–1.89) 2.26 0.1029 0.85
Cases 17 115 338
Controls 18 144 318
rs1877670 0.50 0.4790 0.90 (0.68–1.20) 0.00 0.9959 1.00 (0.72–1.38) 0.22 0.6389 0.96
Cases 91 238 141
Controls 93 253 134
a1: Minor allele; 2: Major allele.
bSignificant P value (,0.05) are in boldface.
cThe software program Finetti (http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl) did not provide 95%CI.
doi:10.1371/journal.pone.0030237.t002
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model or the multiplicative model (the allelic comparisons) may be
more accurate to describe the effect of EGR3 in schizophrenia
etiology [28]. Actually, the ORs for different models for the A-
allele of rs35201266 are in the same direction, suggesting the
increased risk of schizophrenia with the possession of one or more
A alleles.
Furthermore, we stratified the patients by AAO, to examine if
there were any clinical differences between the patients carrying
the different allele of rs35201266. No significant differences were
found between the risk allele (A) carriers and the G homozygotes
of rs35201266 in either the total or the subgroup allele frequency
distribution. Hence, our current study did not indicate an AAO
specific genetic effect.
We also stratified samples by gender, however, there was no
significant difference between males and females in cases
(P=0.0794). Thus, this result did not support a gender specific
association for rs35201266 of EGR3 with schizophrenia [29].
Our independent replication of the association of SNP
rs35201266 with schizophrenia, in consideration with similar
studies, reduces the likelihood that the association we observed was
a false-positive and suggests that EGR3 gene may indeed be a risk
factor for schizophrenia. Recently, the genome-wide association
studies (GWASs) are being widely used to study schizophrenia
because they incorporate a powerful, systematic, and unbiased
genetic approach to the analysis of complex diseases [2]. We
summarized the findings of several GWASs that have detected
associations with genetic variants in the vicinity of chromosome
8p, the same region that contains EGR3, and schizophrenia.
Interestingly, the positive association between chromosome 8p and
schizophrenia was identified at least in four different ethnic
populations from three GWASs [23,24,25], however, the most
significant candidate gene was not EGR3. Since the variants of
EGR3 locus may not surpass the level of genome-wide significance
in GWA studies [30], the susceptibility of EGR3 to schizophrenia
cannot be excluded by GWASs. Hence, much work is still to be
done to identify the contribution of EGR3 to the involvement in
genetic risk for schizophrenia.
To further confirm or exclude the implication of EGR3 in
association with schizophrenia, we performed a meta-analysis. We
did not detect significant heterogeneity between the available
studies, and this enabled us to test three SNPs (rs1008949,
rs35201266 and rs3750192) for association with schizophrenia
using a fixed-effects meta-analysis. We found a statistically
significant association between rs35201266 and schizophrenia
(P=0.0001) in various East Asian populations. The estimates of
the combined OR of rs35201266 ranged from 1.12 to 1.43,
suggesting that the data from Kim’s study [11] and our study
affected the combined estimate, whereas, the study of Yamada et
al. also showed an increase of risk allele in cases compared to
controls (34.3% vs 31.9%) [8]. The results of our meta-analysis
suggest that EGR3 may have a small, but significant effect in the
susceptibility to the development of schizophrenia, at least in the
tested East Asian populations [31].
Specifically, we observed that the A-allele of rs35201266, and
haplotypes comprised of the A-allele, were over-represented in
patients with schizophrenia. As mentioned earlier, rs35201266 (A/
G) is located in intron 1 of EGR3. In an in vitro study, the A-allele
was associated with reduced expression of EGR3, suggesting that
its function may be regulatory [8]. Reduced expression of EGR3
has also been observed in patients with schizophrenia [8,17].
Hence, the findings of our study are consistent with previous
studies. Therefore, our study provides additional support for the
possibility of SNP rs35201266 possessing a biological function in
schizophrenia susceptibility.
EGR3 may play a very important role in the pathological
mechanism underlying schizophrenia. EGR32/2 mice were
Figure 2. LD between markers genotyped in the EGR3 gene
locus in Han Chinese. LD structure (D9) between marker pairs is
indicated by the shaded matrices. The figure was generated using
HaploView 4.1.
doi:10.1371/journal.pone.0030237.g002
Table 3. Estimated frequency of haplotype and association significance.
No. of
Markers Haplotype Global P
a
Alleles Increasing in
Cases
Estimated Haplotype
Frequency(%) P value
a OR (95% CI)
Cases Controls
2 rs1008949-rs35201266 0.0330 C-A 17.8 14.5 0.0445 1.29 (1.00–1.65)
rs35201266-rs3750192 0.0012 A-G 11.4 6.8 0.0005 1.77 (1.27–2.47)
3 rs1008949-rs35201266-rs3750192 0.0246 C-A-G 9.3 6.1 0.0083 1.59 (1.11–2.27)
rs35201266-rs3750192-rs1877670 0.0180 A-G-C 7.1 4.5 0.0135 1.64 (1.08–2.47)
aSignificant P values (,0.05) are in boldface.
doi:10.1371/journal.pone.0030237.t003
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abnormalities in social interactions, and deficits in synaptic
plasticity, which model the cognitive deficits of schizophrenia
[16]. The impact of the antipsychotic medication cloazpine
inhibiting the increased aggression and impulsivity behavior of
EGR32/2 mice is very similar with the effects of antipsychotic
medications in schizophrenia patients [32].
In addition to EGR3’s essential function for neuron activity,
EGR3 also interacts with a number of factors implicated in the risk
and pathogenesis of schizophrenia. Such factors include proteins
and microRNAs (miRNAs) that have been reported to-affect/be-
affected by the expression of EGR3. Proteins that have been
reported to affect the expression of EGR3 by induction include N-
methyl-D-aspartate receptors (NMDARs), calcineurin (CN), brain-
derived neurotropic factor (BDNF), and neuregulin (NRG1).
EGR3 can be induced by NMDARs [33], which are highly
permeable to Ca
2+ (Ca
2+ influx through NMDARs is essential for
synaptic plasticity). Hypofunction of the NMDAR pathway has
been reported to contribute to the etiology of schizophrenia in a
number of studies [34,35,36].
EGR3 has been reported to be induced by CN [37,38,39]. CN
is a Ca
2+ and calmodulin-dependent phosphatase participating in
many cellular processes and Ca
2+-dependent signal transduction
pathways [40]. Human genetic association studies and behavioral
analysis of mouse models have provided evidence for the
involvement of CN signaling in schizophrenia susceptibility
[7,41]. CN as an upstream gene for EGR3 might be triggered by
calcium influx through NMDARs [42]. EGR3 is also a target gene
for Brain-derived neurotrophic factor (BDNF) and Neuregulin 1 (NRG1)
[43,44,45], both of which are schizophrenia susceptibility genes
[6,46,47,48,49]. Induction of EGR3 by BDNF enables EGR3 to
control the expression of Gamma-aminobutyric acid receptor (GABAR)
[50], which is also a candidate risk gene for the schizophrenia [51].
In addition to being downstream and upstream of susceptibility
genes, EGR3 has been linked to a number of miRNAs that have
been associated with schizophrenia. MiRNAs are a class of non-
coding small RNAs that negatively regulate gene expression in
numerous biological processes by promoting mRNA degradation
and/or repressing translation through sequence-specific interac-
tions with the 39 UTRs of target mRNAs [52,53]. The miR-15
family was reported to be significantly up-regulated in the
cerebral cortex of schizophrenia patients and was therefore
hypothesized to have a biological influence in the cortex of
schizophrenia patients by influencing genes involved in cortical
structure and neural plasticity [54]. EGR3 is one of the targets
genes for miR-15 family as predicated by the Miranda (http://
www.microrna.org/microrna/home.do) and TargetScan (http://
www.targetscan.org/) websites, consistent with the findings of
elevated expression of miRNAs and decreased expression of
EGR3 in schizophrenia patients. Guo et al. proposed a model
highlighting EGR3 and miRNAs involved in signaling pathways
and regulatory networks in the nervous system [55]. Further
exploration regarding functional relationship between miR-15
family and EGR3 gene involved in the pathogenesis of
schizophrenia will be worthwhile.
We found that rs3750192 was not significantly associated with
schizophrenia, in agreement with two other studies [11,19] and in
contrast to another study [8]. Yamada et al. utilizing a Japanese
sample demonstrated that rs3750192 was associated with
schizophrenia (P=0.0171) [8]. The discrepancy of the results
Table 4. Age at onset and gender analysis of rs35201266 (A/G) in cases.
Age at onset Main effect P value OR (95% CI) Gender Main effect P value
OR (95%
CI)
A carriers
a G homozygote
a A carriers
a G homozygote
a
,15 1.75 (3) 3.34 (10) 0.3119 0.52 (0.11–2.06) Male 46.78 (80) 55.18 (165) 0.0794 0.71 (0.48–
1.06)
15, = and,30 78.36 (134) 78.34 (217) 0.1651 1.37 (0.86–2.19) Female 53.22 (91) 44.82 (134)
30, = and,45 16.95 (29) 22.41 (67) 0.1586 0.71 (0.42–1.18)
45, = 2.92 (5) 1.67 (5) 0.3656 1.77 (0.44–7.16)
Global P 0.2764
aNumber of alleles for each SNP is given in parentheses.
doi:10.1371/journal.pone.0030237.t004
Table 5. Comparison of rs35201266 between current study and the previous studies.
Polymorphsim Studies Ethnicity Sample MAF
b in Control (Allele) Risk Allele P value
c
rs35201266 (A/G) Current Study Chinese Case-Control 0.155 (A) A 0.009
Kim et al., 2010 [11] Korea Case-Control 0.364 (A) A 0.0008
Yamada et al., 2007 [8] Japanese Family-trois Unknown A 0.0009
Japanese Case-Control 0.319 (A) A 0.234
Hapmap
a European Control 0.392 (A) Unknown Unknown
Nigeria (African) Control 0.203 (A) Unknown Unknown
aHapmap:http://hapmap.ncbi.nlm.nih.gov/.
bMAF: Minor Allele Frequency.
cSignificant P value (,0.05) are in boldface.
doi:10.1371/journal.pone.0030237.t005
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different ethnic groups. We also found that SNP rs1008949 was
not associated with schizophrenia, consistent with the findings of
another study (Liu et al.) utilizing a Chinese case-control sample
[18].
The limitation of this study was that our sample was moderate
in size and that there was not sufficient coverage of SNPs to span
the whole sequence of EGR3. However, our results clearly
demonstrate that SNP rs35201266 is significantly associated with
schizophrenia, largely consistent with previous reports. We also
showed that several haplotypes comprised of rs352021266 were
significantly associated with schizophrenia.
In summary, our study provides evidence for the association of
the EGR3 locus and schizophrenia in the Han Chinese population.
Considering the core position of EGR3 in the CN signaling
pathway, and its interaction with a number of candidate risk
factors implicated with schizophrenia, it strongly warrants
investigation of the molecular basis of EGR3 in relationship to
the pathogenesis of schizophrenia.
Materials and Methods
Subjects
The study was approved by the genetic research ethics
committees of Xi’an Jiaotong University School of Medicine.
The informed consent was written and obtained from all
participants. Subjects of the case-control samples consisted of
470 patients with schizophrenia (245 males, mean
age=34.5612.1, AAO=24.267.2; 225 females, mean
age=32.0613.9, AAO=24.168.3) and 480 healthy control
subjects (275 males, mean age=29.4614.3; 205 females, mean
age=29.6614.1). All participants in this study were biologically
Table 6. Summary of GWA studies on chromosome 8p.
GWA Studies Ethnicity Sample Region
Number of
Positive Markers Position (dbSNP 132) P value
Shi et al., 2009 [27] European Ancestry Case-Control 8p23.3-8p21.2 22 549,908-25,655,470 ,9.27610
24
African American Case-Control 8p23.2-8p21.1 22 2,724,897–29,297,518 ,9.26610
24
Yamada et al, 2011 [28] Japanese Family-trios 8p23.3-8p21 37 1,817,045–27,577,392 ,0.05
Ma et al., 2011 [29] Chinese Case-Control 8p23.1-8p22 7 10,022,938–10,062,543 ,5.0610
25
doi:10.1371/journal.pone.0030237.t006
Figure 3. Meta-analysis of case-control studies between EGR3 gene and schizophrenia.
doi:10.1371/journal.pone.0030237.g003
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Psychiatry Department of the First Affiliated Hospital of Xi’an
Jiaitong University School of Medicine according to the Diagnostic
and Statistical Manual of Mental Disorders (DSM-IV) criteria for
schizophrenia. The diagnosis was checked and confirmed by two
independent senior psychiatrists who reviewed the psychiatric case
records and excluded those with organic brain disease, or short-
term drug-induced psychoses, or other symptomatic psychoses.
The normal controls were drawn from a combination of local
volunteers and blood transfusion donors. Subjects with a personal
of family history of mental illness and with current or past evidence
of psychoses were ruled out by psychiatric colleagues. All subjects
were Han Chinese in origin.
Genotyping
We selected four SNPs (rs1008949, rs35201266, rs3750192, and
rs1877670) around the EGR3 gene locus from the dbSNP database
(http://www.ncbi.nlm.nih.gov/projects/SNP/) and the previous
studies [8,11]. These four SNPs span approximately 7.0 kb, with
average interval of approximately 2.3 kb, and the density of SNPs
is better than those GWASs using the 500 K chips (average
interval ,6.0 kb) [56]. In addition, two SNPs (rs35201266 and
rs3750192) have been associated with schizophrenia in previous
studies [8,11]. The marker rs1008949 was studied both in Korean
and Chinese populations [11,18]. SNP rs1877670 was located in
the 39UTR of the EGR3 gene and may play an important role in
expression of EGR3 [57]. DNA was extracted from whole blood
according to a standard protocol of the DNA Isolation Kit for
Mammalian Blood (Tiangen Biotech CO., LTD). Genotyping was
accomplished by allele-specific PCR, methods have been de-
scribed elsewhere [58]. PCR primers used in this study were
designed by a tetra-primer ARMS-PCR primer design program
(http://cedar.genetics.soton.ac.uk/public_html/primer1.html). The
primers sequences are listed in Table S1. To ensure that the obtained
genotypes were valid, re-genotyping was performed on 50 random
DNA samples for each of the four SNPs. All genotypes were in
agreement with the first round of genotyping, and no genotyping
errors were found.
Statistical Analysis
Primary analyses. Hardy-Weinberg equilibrium (HWE)
and genetic models of all the SNPs were assessed using the
software program Finetti (http://ihg2.helmholtz-muenchen.de/
cgi-bin/hw/hwa1.pl). Genotype frequencies were analyzed using
the software program Epi_Info (http://www.cdc.gov/epiinfo/).
Allele frequencies and pair-wise marker LD were analyzed using
the software program Haploview 4.1 [59]. Haplotype frequencies
were estimated using the software program PHASE version 2.2
[60]. Rare haplotypes (i.e., found in less than 5% of both case and
control subjects) were excluded from analysis. The distribution of
global haplotype frequencies in cases and controls was compared
using the software program Epi_Info. Bonferroni corrections were
applied to all multiple statistical tests. The software program
G*Power program [61] was used to determine statistical power of
the case-control sample. Taking into account sample size, the case-
control sample had .86% power to detect a significant association
(a,0.05), when an effect size index corresponding to a ‘‘weak’’
effect (0.2) was used. Furthermore, we applied a more precise
method (http://www.stat.ubc.ca/,rollin/stats/ssize/caco.html)
to calculate our study power according to the ORs and MAFs of
SNP rs35201266 reported by Kim et al., [11] and found that our
current sample had .84% power to detect a significant association
(a,0.05) (two sided test).
Secondary analyses. According to the genotyping data of
rs35201266, the patients were separated into two groups: the risk
allele (A) carriers [heterozygous and homozygous for the allele (A)]
and non-risk allele carriers [homozygous for the allele (G)].To
assess potential clinical differences (i.e., AAO and gender) in
association, chi-squares, OR, and 95% CI for comparison between
subgroups were calculated using the Epi_Info software.
Furthermore, we compared our results with previous association
studies.
Meta-analysis. The studies included in the meta-analysis
were identified using Medline with the search terms ‘EGR3’ and
‘Schizophrenia’. All the data analyzed had been previously
published. The significance of the subtotal OR was determined
by Z test, and the heterogeneity of the group of ORs was assessed
using a chi-square test. All statistical analyses were performed
using the software program RewMan version 5.0 (http://www.
cochrane.org/revman).
Supporting Information
Table S1 Markers and primers used for allele-specific
PCR.
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